International trade · 23/07/2026Updated: 10/17/2026 · 1 min read
U.S. Patent Office Grants Interim Extension to Centanafadine Hydrochloride Patent
Summary
The U.S. Patent and Trademark Office has issued a one-year extension to the term of U.S. Patent No. 8,461,196, allowing Centanafadine Hydrochloride to maintain its patent protection for an additional year.
Original source language: Federal Register — Department of CommerceOpen original release →